• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Rubicon Research Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 34163.0
  • ISIN : INE506V01022
1,466.40 -51 (-3.33%)
  • As on 22 Jul 2026 (EOD)

  • Today’s Low

    1,452.00

  • Today’s High

    1,522.40

  • Open

    1,499.10

  • Perv Close

    1,516.90

  • 52W Low

    570.75

  • 52W High

    1,539.00

Key Indicators

  • P/E(TTM)

    128.73

  • Mar.Cap (₹Cr.)

    24,251.73

  • Div & Yield %

    0.10

  • Book Value(₹)

    81.83

  • Debt-Equity Ratio

    -3.33

  • AGM Date

    22-Jul-2026

  • EPS

    11.38

  • P/E Ratio

    128.73

Financials Ratios

  • Debt-Equity Ratio

    1.11

  • Mar.Cap (₹Cr.)

    24,251.73

  • RONW (%)

    27.11

  • ROCE (%)

    18.42

Score Board

  • Equity (₹ in Cr.)

    16.54

  • BV (₹)

    81.80

  • Sales( ₹ in Cr.)

    1,306.08

  • NP (in Cr.)

    188.17

  • NP Var(%)

    12.0

  • Div%

    150.0

  • CPS (₹)

    13.70

  • EPS (₹)

    11.40

  • Traded Value (₹ in Lakhs)

    24,226.92

  • 52 Week High

    1,539.00

  • 52 Week Low

    570.75

  • Price BSE

    1465.0

  • Price NSE

    1,466.00

  • Market Capital( in Cr.)

    24,226.92

  • P/C Ratio

    107.20

  • P/E Ratio

    128.80

  • Price Vs.BV

    11.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,073.84 630.51 393.52 400.04 331.35 263.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,073.84 630.51 393.52 400.04 331.35 263.02
Other Income 19.68 26.43 25.48 17.38 10.74 18.07
Stock Adjustments 10.94 10.70 49.24 -8.75 5.83 3.63
Total Income 1,104.46 667.64 468.24 408.67 347.92 284.72
EXPENDITURE :            
Raw Materials 319.22 225.15 149.40 94.55 61.15 41.92
Power and Fuel Cost 20.01 18.31 15.71 10.19 6.54 8.11
Employee Cost 127.74 84.71 97.12 59.29 41.29 33.68
Other Manufacturing Expenses 89.09 60.55 50.11 40.30 21.46 14.36
Selling and Administration Expenses 251.11 171.79 104.28 83.51 63.76 66.81
Miscellaneous Expenses 7.72 7.58 7.66 63.39 31.58 12.03
Employee Benefit Expenses 127.74 84.71 97.12 59.29 41.29 33.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 814.89 568.09 424.28 351.21 225.77 176.90
Operating Profit 289.58 99.56 43.97 57.45 122.15 107.82
Interest 34.29 30.53 18.96 9.02 9.00 6.07
Gross Profit 255.29 69.03 25.01 48.43 113.15 101.75
Depreciation 32.01 34.95 36.06 31.51 27.77 18.07
Profit Before Tax 223.28 34.08 -11.05 16.92 85.38 83.68
Current Tax 57.92 11.24 8.32 2.78 21.18 28.34
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.18 -1.51 -2.48 -2.54 11.25 -3.74
Reported Net Profit 167.54 24.35 -16.89 16.68 52.96 59.08
Extraordinary Items -0.85 0.01 0.03 0.36 0.00 1.28
Adjusted Net Profit 168.39 24.34 -16.92 16.32 52.96 57.80
Adjustment below Net Profit 1.96 0.00 0.00 0.01 -0.04 0.00
P & L Balance brought forward 199.09 174.99 42.49 146.18 94.26 35.31
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.30 0.25 0.25 0.51 1.00 0.00
P & L Balance carried down 368.28 199.09 25.34 162.36 146.18 94.39
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2.00 2.00 5.00 0.00 0.00 19.72
Dividend Per Share(Rs) 0.02 0.02 0.50 0.00 0.00 1.97
Earnings Per Share-Unit Curr 10.87 1.60 -33.31 32.91 104.46 116.52
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 43.33 31.29 564.84 845.39 811.56 701.08
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    59.76%

  • Public Share Holding

    40.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 59,258,360 35.83 59,258,360 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 59,258,360 35.83 59,258,360 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 39,060,000 23.62 39,060,000 5
Partnership Firms-Indian (Promoter & Group) 510,000 0.31 510,000 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 39,570,000 23.93 39,570,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,432,126 7.52 12,432,126 39
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 305,620 0.18 305,620 1
Mutual Funds / UTI 11,953,335 7.23 11,953,335 14
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,334,215 2.02 3,334,215 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 28,025,296 16.95 28,025,296 68
2] Non Institution
Bodies Corporate 285,201 0.17 285,201 166
Clearing Members 37,841 0.02 37,841 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,926,041 1.77 2,926,041 670
Foreign Non Institution Other 6,605,156 3.99 6,605,156 2
Hindu Undivided Families 22,512,251 13.61 22,512,251 961
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 499,816 0.30 499,816 2
Individuals holding nominal share capital up to Rs. 1 lakh 5,219,645 3.16 5,219,645 41,326
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 335,901 0.20 335,901 1
Sub Total 38,529,094 23.30 38,529,094 43,179
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 165,382,750 100.00 165,382,750 43,254

Company Background

Rubicon Research LtdPharmaceuticals - Indian - Formulations

  • Rubicon Research Ltd
  • BSE Code : 34163.0
  • ISIN : INE506V01022

  • Incorporation Year

    1999

  • Registered Office

    Medone House B-75 Road No.33
    Wagle Estate, Thane (West),
    Maharashtra-400604

  • Telephone

    022 6141 4000

  • FAX

  • Chairman

    CHANGAVALLI VENKAT

  • Managing Director

  • Company Secretary

    DEEPASHREE OMKAR TANKSALE

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Rubicon Research Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Rubicon Research 1,464.90 1,093.52 1,073.84 128.73 26.05
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77